Martin Hensel

Martin is the Founder of SelfRx Media and editor-in-chief of Insulin Nation. He's a passionate about sharing knowledge with those affected by Diabetes.
Research of Type 1 Diabetes

IFNα Kinoid: A promising vaccine against Type 1 Diabetes

Neovacs — www.neovacs.fr — is a French biotech company focused on the development of Kinoids®, therapeutic vaccines for the treatment…

Read More »
Research of Type 1 Diabetes

Blood glucose-dependent insulin delivery to simplify treatment

We corresponded with Jingqiang Wang and Professor Zhen Gu of UCLA Engineering about their research on glucose-responsive insulin analogs (ref).…

Read More »
Living with Type 1 Diabetes

Newly Diagnosed and Impressed with T1D Technology

We spoke with Leika Scott, age 22 and a 2018 graduate of Saint Anselm College Nursing School who self-diagnosed her…

Read More »
Living with Type 1 Diabetes

Reader Correspondence

Should I get my son a pump Hello My son Abdo 15 Y old, has DM type 1 since Jan…

Read More »
Treatment of Type 1 Diabetes

Auxulin: Hyperglycemic Innovation Driven by Need

We spoke with Tommy Ritz, MBA, and Dr. Jason McDevitt, William & Mary’s Tech Transfer Director about Auxulin – https://auxulin.com/ – the…

Read More »
Treatment of Type 1 Diabetes

Hillo to Remove Burden from your Life

  We spoke with Stéphane Bidet, CEO of Hillo — http://hillo.ai.   “Nicolas Caleca, CSO, and I founded this company…

Read More »
Treatment of Type 1 Diabetes

Wearable Heart Monitor Detects T1D Hypoglycemia

We spoke with Mats Koeneman, MSc and Technical Physician with the REshape Center for Innovation at Radboud University Medical Center,…

Read More »
Living with Type 1 Diabetes

MyGrams Simplifies Carb Counting

We spoke with Daniel Blumer, CEO of MyGrams — https://www.mygrams.com/ — about his food scale smartphone case and app.  …

Read More »
Research of Type 1 Diabetes

Metformin improves insulin sensitivity in overweight/obese adolescents with T1D

We spoke with Kristen Nadeau, MD, MS, (bio) Professor of Pediatrics and Research Director, Pediatric Endocrinology at the University of…

Read More »
Research of Type 1 Diabetes

Diasome’s Liver Targeted Insulin

We spoke with Robert Geho, CEO of Diasome Pharmaceuticals, Inc. — www.diasome.com — about its nanotechnology additive that delivers insulin…

Read More »
Treatment of Type 1 Diabetes

Overnight Dosing Success in T1D Children

We spoke with Ulrike Schierloh, MD who is with the Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, GD de Luxembourg…

Read More »
Research of Type 1 Diabetes

Aaron Kowalski Appointed New JDRF President/CEO

Today, the JDRF announced the appointment of Aaron J. Kowalski, Ph.D., as the nonprofit’s President and Chief Executive Officer. A…

Read More »
Research of Type 1 Diabetes

Oxygen Critical to Practical Islet Transplants

We spoke with Klearchos Papas, PhD about his oxygen generator-based islet ‘tea bag’ transplant device for which the JDRF just…

Read More »
Treatment of Type 1 Diabetes

Better Insulin Dosing via Machine Learning

We spoke with Cyndi Williams, Co-Founder and CEO of Quin — https://quintech.io — about their Insulin Intervention Taxonomy and how…

Read More »
Treatment of Type 1 Diabetes

Medtronic 670G Faulted for Ease of Use

“Closed-loop insulin pump therapy is the most exciting new development in type 1 diabetes in decades because it acts as…

Read More »
Treatment of Type 1 Diabetes

FDA Rejects SGLT Drug Zynquista for T1D Use

The FDA declined to approve Zynquista a drug developed by Sanofi SA and Lexicon Pharmaceuticals intended for use with insulin…

Read More »
Living with Type 1 Diabetes

Study finds ‘no rationale’ to reduce Gluten Intake in High-Risk Children

In an article published in the February issue of Diabetes Care, researchers found no rationale to reduce gluten intake during…

Read More »
Research of Type 1 Diabetes

3D Bio-Printed Bionic Pancreas

We spoke with Michał Wszoła MD, PhD about the 3D Bio-Printed Bionic Pancreas work being done with his team and…

Read More »
Living with Type 1 Diabetes

Carl Armato’s Diabetes Focus at Novant Health

We spoke with Carl Armato, president and CEO of Novant Health ― https://www.novanthealth.org/ — about his T1D journey and his…

Read More »
Research of Type 1 Diabetes

DRI Poseidon Trial Recruiting Children and Adults

We spoke with Camillo Ricordi, MD, Director of the Diabetes Research Institute (DRI) about the Poseidon Trial that is actively…

Read More »
Back to top button